Effects of genetic variations in the Adiponectin pathway genes on the risk of colorectal cancer in the Chinese population
Open Access
- 12 July 2011
- journal article
- Published by Springer Nature in BMC Medical Genetics
- Vol. 12 (1) , 94
Abstract
Background: Decreased expression of adiponectin (ADIPOQ) is associated with an increased risk for developing colorectal cancer (CRC) in humans. This study was designed to determine whether polymorphisms present in theADIPOQand its type 1 receptor (ADIPOR1) could affect the risk of CRC.Methods: We measured five polymorphisms in theADIPOQand two polymorphisms inADIPOR1, and analyzed their associations with CRC risk in 420 CRC patients and 555 age- and gender-matched healthy individuals.Results: Multivariate logistic regression analyses revealed that the CRC risks (adjusted odds ratio and 95% confidence interval) associated with theADIPOR1genotypes were 0.53 (95% CI, 0.35-0.81) for rs12733285C/T, 0.59 (95% CI, 0.45-0.78) for rs1342387A/G, and 0.59 (95% CI, 0.39-0.89) for rs1342387A/A, respectively. Furthermore, the risks were more significant in carriers of the allele A of rs1342387A/G (adjusted OR, 0.59; 95% CI, 0.46-0.77) than noncarriers (G/G). In a further subgroup analysis, we observed that rs266729G/C was associated with an increased risk for colon cancer (adjusted OR, 1.50; 95% CI, 1.05-2.14) but not for rectal cancer (adjusted OR, 0.88; 95% CI, 0.63-1.22), and that carriers of the G allele had an increased risk for developing colon cancer (adjusted OR, 1.45; 95% CI, 1.03-2.05).Conclusions: We conclude that the rs12733285C/T genotype and the carriage of the A allele of rs1342387 (A/G or A/A) inADIPOR1are the protective factors for CRC, while that rs266729G/C and G allele ofADIPOQare the risk factors for colon cancer after excluding rectal cancer cases.Keywords
This publication has 46 references indexed in Scilit:
- Body Size and Incident Colorectal Cancer: A Prospective Study of Older WomenCancer Prevention Research, 2010
- Circulating Adiponectin Is Associated with Obesity and Serum Lipids in West AfricansThe Journal of Clinical Endocrinology & Metabolism, 2010
- Adipocytokines as new promising markers of colorectal tumors: Adiponectin for colorectal adenoma, and resistin and visfatin for colorectal cancerCancer Science, 2010
- Adiponectin and adiponectin receptor in relation to colorectal cancer progressionInternational Journal of Cancer, 2010
- Variants of the Adiponectin (ADIPOQ) and Adiponectin Receptor 1 (ADIPOR1) Genes and Colorectal Cancer RiskJAMA, 2008
- Adipokine genes and prostate cancer riskInternational Journal of Cancer, 2008
- Adiponectin suppresses colorectal carcinogenesis under the high-fat diet conditionGut, 2008
- Variants of the Adiponectin and Adiponectin Receptor 1 Genes and Breast Cancer RiskCancer Research, 2008
- Hereditary colorectal cancer syndromesCancer Causes & Control, 2005
- Overweight, obesity and cancer: epidemiological evidence and proposed mechanismsNature Reviews Cancer, 2004